Merck introduces BrightLab, cloud-based instrument connectivity platform for research scientists Medical Dialogues Bureau15 Feb 2020 10:15 AM ISTGermany: Merck, a leading science and technology company, recently introduced its BrightLab cloud-based inventory management and instrument...
Marksans Pharma Farmingdale facility gets Establishment Inspection Report from USFDA Medical Dialogues Bureau14 Feb 2020 12:57 PM ISTNew Delhi: Drugmaker Marksans Pharma Ltd. recently announced that the company has received Establishment Inspection Report (EIR) from the US...
Coronavirus: Gilead drug remdesivir raises hope for China trials Medical Dialogues Bureau14 Feb 2020 12:42 PM ISTA state-run Chinese research institute applied last week fora patent to use Gilead's experimental drug- remdesivir against the new coronavirus.
CDSCO pulls manufacturers for failing to submit application for category d FDCs; Details Farhat Nasim14 Feb 2020 12:31 PM ISTNew Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has pulled up the Fixed-Dose Combination (FDCs)...
Bayer, Nuvisan ink pact to create new research unit in Berlin Medical Dialogues Bureau14 Feb 2020 10:30 AM ISTThe strategic partnership will lay the foundation for a brand-new research entity to be established by Nuvisan in Berlin. At the same time, it will...
Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images Medical Dialogues Bureau13 Feb 2020 1:44 PM ISTAmsterdam: Royal Philips has announced a new randomized controlled trial to assess patient outcomes after receiving a percutaneous coronary...
Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories Farhat Nasim13 Feb 2020 1:04 PM IST"Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use...1000 mg," the drug firm said in a...
Lupin Pithampur unit gets 2 USFDA observations Medical Dialogues Bureau13 Feb 2020 12:52 PM ISTThe inspection of the company's Pithampur Unit-I facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in...
Novartis cancer therapy MET inhibitor capmatinib granted USFDA priority review Medical Dialogues Bureau13 Feb 2020 9:45 AM ISTCapmatinib (INC280) is an investigational, oral, potent and selective MET inhibitor licensed to Novartis by Incyte Corporation in 2009. Under the...
Wockhardt sells Baddi plant, 62 drug brands to Dr Reddys for Rs 1850 crore Medical Dialogues Bureau12 Feb 2020 5:23 PM ISTCommenting on the acquisition, Dr Reddy's Co-Chairman and Managing Director G V Prasad said," the acquired portfolio shall enhance Dr Reddy''s...
Granules India gets tentative USFDA nod for generic Colchicine capsules Medical Dialogues Bureau12 Feb 2020 2:34 PM ISTNew Delhi: Drug firm Granules India on Tuesday said it has received tentative approval from the US health regulator for its generic Colchicine...
Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA Medical Dialogues Bureau12 Feb 2020 1:10 PM IST"The company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the new drug application...
